-
Alvimopan (trade name Entereg) is a drug
which behaves as a
peripherally acting μ-opioid
receptor antagonist. With the
limited ability to
cross the blood–brain...
- μ-opioid
receptor has been
determined with the
antagonists β-FNA and
alvimopan. Many
structures of the
active state are also available, with agonists...
- also 4-phenylpiperidine derivatives.
Certain other opioids,
including alvimopan, loperamide, and diphenoxylate, are 4-phenylpiperidine
derivatives as...
-
Droxypropine Ketobemidone Methylketobemidone Propylketobemidone Structures Alvimopan Loperamide LS-115509
Picenadol Structures Dextromethadone Dipipanone...
- 6β-Naltrexol-d4 18-MC α-Gliadin β-Chlornaltrexamine β-Funaltrexamine
Akuammine Alvimopan AM-251
Apigenin AT-076
Axelopran Bevenopran Catechin Catechin gallate...
-
affect the
analgesic effects of
opioids within the
central nervous system.
Alvimopan Methylnaltrexone Naloxegol 6β-Naltrexol
Axelopran Bevenopran Methylsamidorphan...
- peripherally-selective
opioid antagonist, such as
methylnaltrexone bromide, naloxegol,
alvimopan, or
naloxone (as in oxycodone/naloxone), may be tried. A 2018 (updated...
- to
design and
develop other opioid receptors antagonists such as
alvimopan.
Alvimopan was
approved later in 2008 for in-hospital use to
increase the gastrointestinal...
- for a
variety of opioids, such as
pethidine (meperidine), ketobemidone,
alvimopan, loperamide, and diphenoxylate. MPTP
Phenylpiperidine Media related to...
- 6β-Naltrexol-d4 18-MC α-Gliadin β-Chlornaltrexamine β-Funaltrexamine
Akuammine Alvimopan AM-251
Apigenin AT-076
Axelopran Bevenopran Catechin Catechin gallate...
